Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 313 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07225621	Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma	recruiting	Phase 2	103	Alpheus Medical, Inc.INDUSTRY	1	Jul 17, 2026	clinicaltrials
NCT03581292	Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations	active not recruiting	Phase 2	38	National Cancer Institute (NCI)NIH	5	Jul 16, 2026